Angelyn Rios

729 total citations
24 papers, 580 citations indexed

About

Angelyn Rios is a scholar working on Immunology, Biotechnology and Genetics. According to data from OpenAlex, Angelyn Rios has authored 24 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Biotechnology and 6 papers in Genetics. Recurrent topics in Angelyn Rios's work include Cancer Research and Treatments (12 papers), Virus-based gene therapy research (6 papers) and Aquaculture disease management and microbiota (4 papers). Angelyn Rios is often cited by papers focused on Cancer Research and Treatments (12 papers), Virus-based gene therapy research (6 papers) and Aquaculture disease management and microbiota (4 papers). Angelyn Rios collaborates with scholars based in United States. Angelyn Rios's co-authors include Richard L. Simmons, Prasanta K. Ray, G Lundgren, Charles F. McKhann, Simmons Rl, Richard L. Simmons, Simmons Rl, John H. Kersey, David Steinmuller and S Magaldi and has published in prestigious journals such as Science, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Angelyn Rios

24 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angelyn Rios United States	15	320	231	163	120	85	24	580
D A Kaplan United States	5	232 0.7×	169 0.7×	131 0.8×	40 0.3×	59 0.7×	7	437
A. Arthur Gottlieb United States	17	303 0.9×	300 1.3×	26 0.2×	74 0.6×	43 0.5×	50	776
Zane Price United States	14	97 0.3×	222 1.0×	39 0.2×	97 0.8×	45 0.5×	21	596
Andreas Lingnau Germany	15	124 0.4×	244 1.1×	304 1.9×	138 1.1×	23 0.3×	23	803
Elisabeth Thomassen United States	13	495 1.5×	766 3.3×	25 0.2×	91 0.8×	171 2.0×	14	1.2k
Marie-Claude Letellier Canada	13	312 1.0×	510 2.2×	261 1.6×	81 0.7×	41 0.5×	19	962
M T Gammon United States	10	696 2.2×	405 1.8×	26 0.2×	98 0.8×	58 0.7×	11	1.0k
H. Blythman France	11	502 1.6×	261 1.1×	333 2.0×	69 0.6×	27 0.3×	16	686
Wolfgang Domzig Germany	10	311 1.0×	95 0.4×	26 0.2×	66 0.6×	24 0.3×	13	518
Benjamin Rovinski Canada	14	127 0.4×	442 1.9×	180 1.1×	234 1.9×	131 1.5×	22	843

Countries citing papers authored by Angelyn Rios

Since Specialization

Citations

This map shows the geographic impact of Angelyn Rios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelyn Rios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelyn Rios more than expected).

Fields of papers citing papers by Angelyn Rios

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelyn Rios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelyn Rios. The network helps show where Angelyn Rios may publish in the future.

Co-authorship network of co-authors of Angelyn Rios

This figure shows the co-authorship network connecting the top 25 collaborators of Angelyn Rios. A scholar is included among the top collaborators of Angelyn Rios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelyn Rios. Angelyn Rios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magaldi, S, et al.. (2001). In vitro susceptibility to fluconazole of Candida spp. isolates comparing three different methods. Journal de Mycologie Médicale. 11(3). 123–126. 11 indexed citations

Toledo‐Pereyra, Luis H., et al.. (1984). NEW AVENUES IN THE USE OF CYCLOSPORIN FOR TRANSPLANTATION. GRAFT AND DONOR PRETREATMENT. Immunological Communications. 13(6). 523–538. 1 indexed citations

Rossen, Roger D., et al.. (1978). Response of malignant melanoma to plasma exchange, surgical debulking, and Corynebacterium parvum.. PubMed. 1(1). 53–7. 2 indexed citations

Simmons, Richard L., Angelyn Rios, Luis H. Toledo‐Pereyra, & David Steinmuller. (1975). Modifying the Immunogenicity of Cell Membrane Antigens: Tumors and Transplants. American Journal of Clinical Pathology. 63(5). 714–734. 8 indexed citations

Rios, Angelyn & Richard L. Simmons. (1974). Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase‐treated tumor cells. International Journal of Cancer. 13(1). 71–81. 34 indexed citations

Rios, Angelyn & Simmons Rl. (1974). Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.. PubMed. 75(4). 503–7. 5 indexed citations

Simmons, Richard L. & Angelyn Rios. (1974). Cell surface modification in the treatment of experimental cancer: Neuraminidase or concanavalin a. Cancer. 34(S8). 1541–1547. 28 indexed citations

Simmons, Richard L. & Angelyn Rios. (1973). Differential Effect of Neuraminidase on the Immunogenicity of Viral Associated and Private Antigens of Mammary Carcinomas. The Journal of Immunology. 111(6). 1820–1825. 15 indexed citations

Rios, Angelyn & Richard L. Simmons. (1973). Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.. PubMed. 51(2). 637–44. 31 indexed citations

10.

Simmons, Richard L., Angelyn Rios, & John H. Kersey. (1972). Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG. Journal of Surgical Research. 12(2). 57–61. 14 indexed citations

11.

Rios, Angelyn & Richard L. Simmons. (1972). Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.. PubMed. 32(1). 16–21. 21 indexed citations

12.

Rl, Simmons & Angelyn Rios. (1972). Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase.. PubMed. 71(4). 556–64. 17 indexed citations

13.

Rios, Angelyn & Richard L. Simmons. (1972). POLY-2-VINYLPYRIDINE N-OXIDE REVERSES THE IMMUNOSUPPRESSIVE EFFECTS OF SILICA AND CARRAGEENAN. Transplantation. 13(3). 343–344. 39 indexed citations

14.

Simmons, Richard L. & Angelyn Rios. (1972). Immunospecific Regression of Methylcholanthrene Fibrosarcoma Using Neuraminidase. Annals of Surgery. 176(2). 188–194. 21 indexed citations

15.

Simmons, Richard L., Angelyn Rios, Prasanta K. Ray, & G Lundgren. (1971). Effect of Neuraminidase on Growth of a 3-Methylcholanthrene-Induced Fibrosarcoma in Normal and Immunosuppressed Syngeneic Mice<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 47(5). 1087–94. 40 indexed citations

16.

Simmons, Richard L., et al.. (1971). Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.. PubMed. 70(1). 38–46. 76 indexed citations

17.

Simmons, Richard L. & Angelyn Rios. (1971). Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCG. Science. 174(4009). 591–593. 96 indexed citations

18.

Simmons, Richard L., et al.. (1971). Failure of Neuraminidase to unmask Histocompatibility Antigens on Trophoblast. Nature New Biology. 231(21). 111–112. 39 indexed citations

19.

Rios, Angelyn & Simmons Rl. (1970). Immunosuppressive effects of macrophage lysis.. PubMed. 21. 272–3. 3 indexed citations

20.

Rl, Simmons, et al.. (1970). Mechanism of neuraminidase induced antigen "unmasking".. PubMed. 21. 265–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact